Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
Clinical trial NCT04273945 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04273945
- Sponsor
- Actelion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2025-10-07
- Enrollment
- 935
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.